Skip to main content

Table 4 Intraoperative and postoperative characteristics in patients with EuroSCORE II ≥ 4.15

From: The impact of glutamate infusion on postoperative NT-proBNP in patients undergoing coronary artery bypass surgery: a randomized study

Variables

EuroSCOREII ≥ 4.15

(n = 101)

Glutamate

(n = 56)

Control

(n = 45)

p-value

Aortic crossclamp time (min)

53 [42–67]

54 [41–65]

52 [42–67]

0.91

CPB time (min)

80 [65–106]

81 [64–104]

79 [67–107]

0.74

Reperfusion time (min)

23 [16–30]

24 [17–30]

21 [16–29]

0.53

NT-proBNP POD1 (ng•L−1)

4170 [2850–6185]

3786 [2630–5380]

4675 [3010–6650]

0.21

NT-proBNP POD3 (ng•L−1)

6650 [3800–9970]

4845 [3426–7423]

8430 [5370–14,100]

0.001

Delta NT-proBNP POD1-Pre (ng•L−1)

2800 [1650–4760]

2653 [1540–3675]

3050 [2030–5560]

0.13

Delta NT-proBNP POD3-Pre (ng•L−1)

5210 [3115–8595]

3900 [2995–6260]

6745 [3455–12,687]

0.012

CK-MB POD1 (µg•L−1)

18 [11–25]

14 [9–23]

19 [12–26]

0.12

TroponinT POD3 (ng•L−1)

390 [190–730]

290 [160–480]

550 [210–860]

0.015

Delta Troponin T POD3-Pre (ng•L−1)

270 [135–600]

270 [130–450]

350 [150–680]

0.44

Inotropic support

43% (43)

43% (24)

42% (19)

1.00

ICU stay (h)

22 [19–42]

21 [19–26]

25 [22–45]

0.022

ICU stay > 72 h

18% (18)

16% (9)

20% (9)

0.61

Ventilation time (h)

5 [3–12]

4 [3–9]

5 [3–20]

0.3

Ventilation time > 48 h

11% (11)

11% (6)

11% (5)

1

PHF

22% (22)

15% (8)

31% (14)

0.053

Severe PHF

9% (9)

4% (2)

16% (7)

0.074

Postoperative stroke

4% (3)

4% (2)

4% (2)

1

AKI

29% (29)

25% (14)

33% (15)

0.51

Hospital Mortality

5% (5)

4% (2)

7% (3)

0.65

  1. Data given as medians [interquartile range] or percentages (number)
  2. AKI acute kidney injury, CK-MB creatine kinase-MB isoenzyme, CPB cardiopulmonary bypass, ICU intensive care unit, PHF postoperative heart failure, POD postoperative day